“Frustrating” Sigma Labs delays cause its revenue to decline 14%
Quality assurance software developer Sigma Labs (NASDAQ: SGLB) has revealed that its revenue fell 14% in Q2 2021 due to an unforeseen series of contract delays. Over the second quarter of 2021, the company generated an income of just $144,000, $24,000 less than the $168,000 reported in Q2 2020. This decline was primarily caused by […]
Go to Source
Author: Paul Hanaphy
